-
Mar 25, 2013 07:19AM
Baird Upgrades Endocyte (ECYT) to Outperform
-
Apr 16, 2012 12:12PM
Streetinsider.com's Hot Lunchtime Reads 04/16: (BBY) (EMC) (ECYT) (TAN) (NFLX)
-
Apr 16, 2012 10:55AM
Baird Lifts Price Target on Endocyte (ECYT) Following Transformational Merck Deal
-
Mar 5, 2012 11:20AM
Baird Reiterates a 'Neutral' on Endocyte (ECYT); Remaining on Sidelines Until Better EC145 Efficacy
-
Dec 14, 2011 08:42AM
Baird Downgrades Endocyte (ECYT) to Neutral
-
Dec 13, 2011 02:28PM
Unusual 11 Mid-Day Movers 12/13: (SYNO) (SSW) (YMI) Higher; (ECYT) (AMPE) (IVN) (IDT) Lower
-
Dec 13, 2011 11:31AM
Morning Movers 12/13: (SYNO) (CCMP) (SSW) Higher; (ECYT) (IVN) (CMED) (IDT) Lower
-
Dec 13, 2011 09:37AM
Baird Downgrades Endocyte (ECYT) to Neutral; EU Conditional Approval Now Decidedly Less Certain
-
Sep 28, 2011 07:17AM
Baird Reiterates an 'Outperform' on Endocyte (ECYT); Doxil Shortage May Present a Real Risk to PROCEED Timelines
-
Aug 19, 2011 08:57AM
Baird Reiterates an 'Outperform' on Endocyte (ECYT); Remains Top Small-Cap Pick
-
Mar 16, 2011 07:01AM
Baird Starts Endocyte (ECYT) at Outperform, Sees 100% Upside
-
Feb 3, 2011 12:54PM
Endocyte (ECYT) Prices IPO at $6